RU2018147553A3 - - Google Patents

Download PDF

Info

Publication number
RU2018147553A3
RU2018147553A3 RU2018147553A RU2018147553A RU2018147553A3 RU 2018147553 A3 RU2018147553 A3 RU 2018147553A3 RU 2018147553 A RU2018147553 A RU 2018147553A RU 2018147553 A RU2018147553 A RU 2018147553A RU 2018147553 A3 RU2018147553 A3 RU 2018147553A3
Authority
RU
Russia
Application number
RU2018147553A
Other languages
Russian (ru)
Other versions
RU2018147553A (en
RU2741095C2 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to RU2018147553A priority Critical patent/RU2741095C2/en
Publication of RU2018147553A3 publication Critical patent/RU2018147553A3/ru
Publication of RU2018147553A publication Critical patent/RU2018147553A/en
Application granted granted Critical
Publication of RU2741095C2 publication Critical patent/RU2741095C2/en

Links

RU2018147553A 2018-12-29 2018-12-29 Method of producing cell lines stably producing human monoclonal antibodies of class igg RU2741095C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2018147553A RU2741095C2 (en) 2018-12-29 2018-12-29 Method of producing cell lines stably producing human monoclonal antibodies of class igg

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2018147553A RU2741095C2 (en) 2018-12-29 2018-12-29 Method of producing cell lines stably producing human monoclonal antibodies of class igg

Publications (3)

Publication Number Publication Date
RU2018147553A3 true RU2018147553A3 (en) 2020-06-29
RU2018147553A RU2018147553A (en) 2020-06-29
RU2741095C2 RU2741095C2 (en) 2021-01-22

Family

ID=71509320

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018147553A RU2741095C2 (en) 2018-12-29 2018-12-29 Method of producing cell lines stably producing human monoclonal antibodies of class igg

Country Status (1)

Country Link
RU (1) RU2741095C2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4764465A (en) * 1984-04-26 1988-08-16 Cetus Corporation Human monoclonal antibody against group A red blood cells
WO2010017381A2 (en) * 2008-08-07 2010-02-11 The Regents Of The University Of Colorado, A Body Corporate Methods for the diagnosis of varicella zoster virus infection
CA2778953C (en) * 2009-11-13 2020-01-14 Dana-Farber Cancer Institute, Inc. Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
CN111499755A (en) * 2012-08-03 2020-08-07 丹娜法伯癌症研究院 anti-PD-L1 and PD-L2 double-binding antibody single reagents and methods of use thereof

Also Published As

Publication number Publication date
RU2018147553A (en) 2020-06-29
RU2741095C2 (en) 2021-01-22

Similar Documents

Publication Publication Date Title
BR112021012225A2 (en)
BR122022006221A2 (en)
BR122022015534A2 (en)
BR112021008873A2 (en)
BR122022002096A2 (en)
AT524834A2 (en)
AT524874A5 (en)
AU2018438767B1 (en)
AT524961A5 (en)
BR122022005529A2 (en)
BR122022016585A2 (en)
BR112020012832A2 (en)
BR202018071071U8 (en)
BR102018070765A2 (en)
BR102018016915A2 (en)
BE2018C025I2 (en)
BR112020025288A2 (en)
BR202018008879U2 (en)
BR202018007669U2 (en)
BR202018006247U2 (en)
BR202018004136U2 (en)
BR202018002487U2 (en)
BR202018002069U2 (en)
CN304434040S (en)
CN304439854S (en)